Mobile phone related articles are
Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Study type | Study group | Observation period | Study location | Endpoints | Parameters |
---|---|---|---|---|---|---|---|
Eger H et al. | 2004 | - | men, women | 1994 - 2004 | Germany | tumors of breast, ovaries, prostate, pancreas, intestine, skin, lung, kidney, stomach, bladder, and blood | mobile communications, digital mobile phone, mobile phone base station, residential |
Nelson PD et al. | 2006 | - | men, women | 1979 - 2001 | UK | acoustic neuroma, other benign cranial nerve neoplasms | mobile communications, analog mobile phone, digital mobile phone, personal |
Czerninski R et al. | 2011 | - | men, women | 1970 - 2006 | Israel | major salivary gland cancer: parotid gland cancer, submandibular gland cancer, sublingual gland cancer | mobile phone, mobile communications, personal |
de Vocht F | 2011 | - | men, women | 1986 - 2008 | UK | parotid cancer (malignant neoplasms of the parotid gland and for other and unspecified major salivary glands) | mobile communications, mobile phone, personal |
Wolf R et al. | 2004 | - | men, women | July 1997 - June 1998 | Israel | all cancer | mobile communications, mobile phone base station, TDMA, residential |
Stewart A et al. | 2012 | - | men, women, 20–80 years | 1975 - 2010 | UK | breast cancer, gastrointestinal cancer, lung cancer, prostate cancer, non-melanoma skin cancer, all cancer | mobile phone base station, mobile communications, residential |
Shu X et al. | 2012 | - | men, women, ≥ 20 years | 1970 - 2009 | Sweden, Denmark, Finland, Norway, and Island | malignant parotid gland tumor, all malignant salivary gland tumors | mobile phone, mobile communications, personal |
Carlberg M et al. | 2016 | - | men, women, children, 0–80 years | 1970 - 2013 | Sweden, Denmark, Finland, Norway and Iceland | thyroid cancer | mobile phone, mobile communications, cordless phone, also other exposures without EMF |
Inskip PD et al. | 2003 | - | men, women | 1974 - 1998 | USA | Augen-Melanom | mobile phone, mobile communications, also other exposures without EMF |
Luo J et al. | 2019 | - | men, women, 21–84 years | 2010 - 2011 | USA | thyroid cancer | mobile communications, mobile phone |
Gao H et al. | 2019 | - | - | 2004 - 2015 | UK | all cancer | mobile communications, TETRA/TETRAPOL, occupational |
Luo J et al. | 2020 | - | men, women, 21–84 years | 2010 - 2011 | USA | thyroid cancer | mobile communications, mobile phone |
López I et al. | 2021 | - | men, women | 2019 | Spain | sleep duration, time to fall asleep, nightmares, headache, dizziness, fainting, tachycardia and tiredness, all cancer | mobile communications, mobile phone base station, UMTS, GSM, CDMA, LTE, DECT, RF field, Bluetooth, W-LAN/WiFi |
Karipidis K et al. | 2021 | - | men, women | 1982 - 2016 | Australia | parotid gland cancer and other types of salivary gland cancers | mobile communications, mobile phone |
de Vocht F | 2021 | - | men, women | 1996 - 2017 | UK | brain tumor, cancer of the parotid gland, cancer of the thyroid gland, cancer of the colon and rectum | mobile communications, mobile phone |
Peleg M et al. | 2023 | - | men, women | 2019 - 2021 | Israel | leukemia and lymphoma, sarkoma | mobile communications, radar, wireless transmitter, occupational |
Zhang Y et al. | 2024 | - | men, women, 37–73 years | - | United Kingdom | head and neck, esophagus, stomach, small intestine, colorectum, anus and anal canal, liver, pancreas, lung, melanoma, nonmelanoma skin cancer, mesothelial and soft tissue, vulva, cervix, uterus, ovary, prostate, kidney, urinary tract, thyroid gland, brain/CNS/ intracranial cancer, glioma, breast cancer, overall cancer, leukemia, non-Hodgkin lymphoma and multiple myeloma | mobile communications, mobile phone |
Stang A et al. | 2001 | case-control study | men, women, 35–74 years | July 1995 - March 1998 | Germany | uveal melanoma | mobile communications, analog mobile phone, digital mobile phone, RF field, cordless phone, radar, wireless transmitter, power transmission line, PC/TV monitor, occupational, personal |
De Roos AJ et al. | 2001 | case-control study | men, women, children, 0–18 years | 1992 - 1994 | USA and Canada | neuroblastoma | mobile communications, mobile phone, mobile phone base station, Radio/TV transmitter, radar, RF field, magnetic field, low frequency, 50/60 Hz, power transmission line, high volt./current device/welder, occupational, also other exposures without EMF |
Auvinen A et al. | 2002 | case-control study | men, women, 20–69 years | 1996 | Finland | brain tumor, salivary gland cancer | mobile communications, analog mobile phone, digital mobile phone, personal |
Warren HG et al. | 2003 | case-control study | men, women, ≥ 18 years | July 1995 - July 2000 | USA | intratemporal facial nerve tumor | mobile communications, analog mobile phone, digital mobile phone, cordless phone, personal |
Hardell L et al. | 2004 | case-control study | men, women, 21–80 years | 1994 - 1999 | Sweden | salivary gland tumour | mobile communications, analog mobile phone, digital mobile phone, GSM, NMT, cordless phone, personal |
Lönn S et al. | 2006 | case-control study | men, women, 20–69 years | September 2000 - August 2002 | Denmark, Sweden | parotid gland tumor | NMT, mobile communications, mobile phone, analog mobile phone, digital mobile phone, GSM, personal |
Hardell L et al. | 2007 | case-control study | men, 20–75 years | 1993 - 1997 | Sweden | testicular cancer: seminoma and non-seminoma | mobile communications, analog mobile phone, digital mobile phone, GSM, NMT, cordless phone, personal |
Sadetzki S et al. | 2008 | case-control study | men, women, ≥ 18 years | January 2001 - December 2003 | Israel | benign and malignant parotid gland tumors | mobile communications, analog mobile phone, digital mobile phone, personal |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.